Rural OBOT Financial Sustainability-Recording - Rural OBOT Financial Sustainability

Video Transcription

Video Summary

Dr. William Maroney discusses rural office-based opioid treatment (OBOT) and how to make it financially and clinically sustainable in underserved communities. He emphasizes that rural areas face major barriers to medication for opioid use disorder (MOUD), including distance, transportation, poverty, broadband limits, workforce shortages, and fewer pharmacies, hospitals, and specialty services. He also argues that stigma is not only found in the community, but within healthcare systems and even among treatment providers who favor abstinence-only approaches over medications like buprenorphine, methadone, and naltrexone.<br /><br />Maroney highlights that overdose deaths, especially from fentanyl and other opioids, remain a leading cause of accidental death and are especially severe in rural regions. He argues that telehealth has become a major solution after COVID, helping patients access care without missing work or traveling long distances. He presents telehealth outcomes as comparable to in-person care and stresses that medication alone is not enough: counseling, motivational interviewing, CBT, contingency management, and wraparound case management are essential for recovery.<br /><br />The lecture calls for integrated care models that combine medical treatment, counseling, and harm reduction, with flexible scheduling and strong collaboration between prescribers, therapists, and community supports. Maroney concludes that reducing stigma, building trust, and adapting care to rural realities are necessary to improve retention, outcomes, and financial viability.

Keywords

rural OBOT

opioid use disorder

MOUD

telehealth

buprenorphine

methadone

naltrexone

stigma reduction

harm reduction

rural healthcare